Avastin Dramatically Improves Response, Survival In Deadly Recurrrent Glioblastomas, Study Finds

A study has found that targeted therapy Avastin, alone and in combination with the chemotherapy drug CPT-11, significantly increased response rates, progression-free survival times and survival rates in patients with a deadly form of brain cancer that had recurred.

Read the whole article on Science Daily

More from Science Daily